Utipro® Plus AF is intended for the control and prevention of urinary tract infections produced by pathogens such as E.coli and other gram (-) bacteria normally involved in the etiology of urological infections.
The compound, based on Xyloglucan (Hemicellulose) and Gelose, acts mechanically in the intestinal lumen, avoiding the contact of the pathogens with the intestinal mucosa, which is the first step for their proliferation and subsequent passage to the urinary tract.
Utipro® Plus AF is to be taken orally, from the appearance of the first symptoms of urinary tract disorders, with the aim of reducing the proliferation of pathogens that may degenerate into infections. In case of infection recurrences, Utipro® Plus AF is also intended for the prevention of new episodes, in which the proliferation of pathogen cause repeated urinary tract infection.
Utipro® Plus AF complies the Essential Requirements of Directive 93/42/EEC and subsequent amendments.